Company intelligence / Profile preview

Research and Development Center

Ownership: Private
Development stage: Other

Overview

Research and Development Center is a biotechnology company focused on the development and manufacturing of vaccines and therapeutic biologics. The company specializes in infectious disease prevention, maintaining a robust portfolio of commercialized vaccines for influenza and hepatitis. Beyond its established products, the center actively pursues innovative research in recombinant protein technology and monoclonal antibodies to address emerging viral threats. Its operations encompass the full lifecycle of drug development, from early-stage discovery to large-scale GMP manufacturing.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicMonoclonal antibodyRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Research and Development Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Research and Development Center.

Explore the full profile